Milan Site_GMP

  • Surface area: about 1.500 mq (16.000 SQF) dedicated to development, testing and production according to cGMP.
  • Authorization to produce drugs for clinical and commercial use (2003 and 2015).
  • More than 150 GMP batches of viral vectors and over 200 batches of genetically modified cells to support more than 20 clinical trials in Europe and the US